| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |